HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 67.50
-0.80 (-1.17%)
Sep 5, 2025, 1:29 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 3.11 billion as of September 5, 2025. Its market cap has decreased by -3.85% in one year.
Market Cap
3.11B
Enterprise Value
2.71B
Revenue
304.45M
Ranking
n/a
PE Ratio
23.68
Stock Price
67.50
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 3.11B, a decrease of -25.33%. That is a compound annual growth rate of -13.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 3.11B | - |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 90.84B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 40.77B |
| Oneness Biotech | 36.44B |
| Polaris Group | 29.47B |
| Center Laboratories | 28.63B |